Brokerages Set Centrica (CNA) Target Price at $178.69

Shares of Centrica (LON:CNA) have received a consensus rating of “Hold” from the eighteen brokerages that are presently covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is GBX 178.69 ($2.56).

Several research analysts have issued reports on CNA shares. Credit Suisse Group restated a “neutral” rating and set a GBX 175 ($2.51) price target on shares of Centrica in a report on Wednesday, January 3rd. Deutsche Bank reiterated a “sell” rating and issued a GBX 125 ($1.79) price objective on shares of Centrica in a research note on Friday, January 12th. JPMorgan Chase reiterated a “neutral” rating and issued a GBX 150 ($2.15) price objective on shares of Centrica in a research note on Tuesday, February 20th. Royal Bank of Canada upgraded shares of Centrica to an “outperform” rating and lifted their price objective for the company from GBX 150 ($2.15) to GBX 175 ($2.51) in a research note on Monday, February 26th. Finally, Kepler Capital Markets lowered their price objective on shares of Centrica from GBX 190 ($2.72) to GBX 160 ($2.29) and set a “buy” rating for the company in a research note on Wednesday, February 28th.

How to Become a New Pot Stock Millionaire

In other Centrica news, insider Stephen Pusey purchased 1,678 shares of Centrica stock in a transaction that occurred on Monday, January 22nd. The stock was acquired at an average price of GBX 139 ($1.99) per share, with a total value of £2,332.42 ($3,339.66). Also, insider Margherita D. Valle purchased 1,368 shares of Centrica stock in a transaction that occurred on Monday, February 26th. The stock was acquired at an average cost of GBX 145 ($2.08) per share, with a total value of £1,983.60 ($2,840.21). In the last three months, insiders purchased 44,985 shares of company stock valued at $6,335,510.

Centrica stock traded up GBX 2.30 ($0.03) during mid-day trading on Thursday, hitting GBX 142.80 ($2.04). 18,682,864 shares of the stock were exchanged, compared to its average volume of 26,600,000. Centrica has a 12 month low of GBX 119.71 ($1.71) and a 12 month high of GBX 221 ($3.16).

Centrica (LON:CNA) last released its quarterly earnings results on Thursday, February 22nd. The integrated energy company reported GBX 12.60 ($0.18) earnings per share (EPS) for the quarter, hitting the consensus estimate of GBX 12.60 ($0.18). Centrica had a net margin of 2.16% and a return on equity of 21.95%. The firm had revenue of GBX 2,802.30 billion during the quarter.

The firm also recently declared a dividend, which will be paid on Thursday, June 28th. Investors of record on Thursday, May 10th will be given a GBX 8.40 ($0.12) dividend. The ex-dividend date is Thursday, May 10th. This represents a yield of 5.83%. This is an increase from Centrica’s previous dividend of $3.60.

TRADEMARK VIOLATION WARNING: This story was first reported by registrarjournal.com and is owned by of registrarjournal.com. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://registrarjournal.com/2018/04/17/brokerages-set-centrica-cna-target-price-at-178-69.html.

About Centrica

Centrica plc operates as an integrated energy company in the United Kingdom, the Republic of Ireland, North America, Norway, and internationally. The company operates through Energy Supply & Services?UK & Ireland, Energy Supply & Services?North America, Connected Home, Distributed Energy & Power, Energy Marketing & Trading, Exploration & Production, Central Power Generation, and Centrica Storage segments.

Analyst Recommendations for Centrica (LON:CNA)

Receive News & Ratings for Centrica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centrica and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply